MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202541020741 A) filed by Dr. Reddys Institute Of Life Sciences on March 07, 2025, for Guide Rna(s), Crispr Complex And Method(s) For Targeting Human Papilloma Virus (hpv).
Inventors include Kiranam Chatti; Christopher Shamir Muggalla; and Srinivas Oruganti.
The application for the patent was published on September 11, 2026, under issue no. 37/2026.
Abstract: ABSTRACT “GUIDE RNA(s), CRISPR COMPLEX AND METHOD(S) FOR TARGETING HPV HUMAN PAPILLOMA VIRUS (HPV) The present provides means and methods for efficient targeting and inactivation of HPV in infected 5 cells in case of HPV infection. The present invention is based on the rationale that a locally delivered targeted nuclease to cause HPV gene knockout is a safe and effective strategy for therapy of HPV and HPV-associated cancers. Accordingly, to facilitate the said targeting provided herein are guide RNA sequence(s), CRISPR-Cas system(s) comprising the same, composition(s) and method(s) for targeting specific genes in the Human Papilloma Virus (HPV) genome. The guide 10 RNA sequence(s) show high stability and strong Cas interaction.
Disclaimer: Curated by HT Syndication.
